Latest News

Pandemic prescribing – what changed?

 

Use of disease-modifying therapies for MS changed substantially during the pandemic among clinicians and patients, according to two studies presented at the European Academy of Neurology (EAN) 2022 annual meeting. Read More

TOPICS: